. 2015 Oct 19;7(5):1759091415609613. doi: 10.1177/1759091415609613

Table 1.

Patient Summary.

Patient number^a	Diagnosis	Age	Gender	MRI activity	AGS score^b	% AGS⁺ B cells^c
1	RRMS	19	F	GD⁺	17.6	22
2	ON_CIS	40	F	GD⁺	6.1	50
3	ON_CIS	40	F	GD⁺	10.7	27
4	TM_CIS	28	F	GD⁺	17.9	18
5	TM_CIS	20	F	GD⁺	16.7	28
6	TM_CIS	33	M	GD⁺	22.3	13
7	RRMS	32	F	GD⁺	14.0	14
8	RRMS	44	F	GD⁺	14.0	11
9	RRMS	35	F	GD⁺	15.0	23
10	ON_CIS	34	F	GD⁺	13.1	25
11	TM_NMO	57	F	GD⁺	13.8	12

Note. AGS = antibody gene signature; GD⁺= gadolinium enhancing lesion positive; F = female; M = male; MRI = magnetic resonance imaging; ON_CIS = clinically isolated syndrome with optic neuritis symptoms; RRMS = relapsing remitting multiple sclerosis; TM_CIS = transverse myelitis; T_NMO = transverse myelitis that converted to neuromyelitis optica.

Overall antibody repertoire data were originally presented for Patient 7 in (Monson et al., 2005), Patients 8 and 9 in (Harp et al., 2007), Patients 4, 5, and 6 in the study by Ligocki et al. (2013) and Patients 1, 3, and 10 in the study by Rounds et al. (2014). ^bAGS scores were originally presented for Patients 7 to 9 in the study by Cameron et al. (2009) and Patients 1, 3 to 6, and 10 in the study by Rounds et al. (2014). ^cAGS+ B cells indicate percent of B cells in the CSF of the patient that had 2 or more mutated AGS codons.